Cargando…
Response to Comment on “Heterogeneity in PD-L1 expression in malignant peritoneal mesothelioma with systemic or intraperitoneal chemotherapy”
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7961136/ https://www.ncbi.nlm.nih.gov/pubmed/33318658 http://dx.doi.org/10.1038/s41416-020-01215-7 |
| _version_ | 1783665193117548544 |
|---|---|
| author | White, Michael G. Eng, Oliver S. |
| author_facet | White, Michael G. Eng, Oliver S. |
| author_sort | White, Michael G. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7961136 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-79611362021-12-14 Response to Comment on “Heterogeneity in PD-L1 expression in malignant peritoneal mesothelioma with systemic or intraperitoneal chemotherapy” White, Michael G. Eng, Oliver S. Br J Cancer Correspondence Nature Publishing Group UK 2020-12-14 2021-03-16 /pmc/articles/PMC7961136/ /pubmed/33318658 http://dx.doi.org/10.1038/s41416-020-01215-7 Text en © Cancer Research UK 2020 https://creativecommons.org/licenses/by/4.0/ Note This work is published under the standard license to publish agreement. After 12 months the work will become freely available and the license terms will switch to a Creative Commons Attribution 4.0 International (CC BY 4.0). |
| spellingShingle | Correspondence White, Michael G. Eng, Oliver S. Response to Comment on “Heterogeneity in PD-L1 expression in malignant peritoneal mesothelioma with systemic or intraperitoneal chemotherapy” |
| title | Response to Comment on “Heterogeneity in PD-L1 expression in malignant peritoneal mesothelioma with systemic or intraperitoneal chemotherapy” |
| title_full | Response to Comment on “Heterogeneity in PD-L1 expression in malignant peritoneal mesothelioma with systemic or intraperitoneal chemotherapy” |
| title_fullStr | Response to Comment on “Heterogeneity in PD-L1 expression in malignant peritoneal mesothelioma with systemic or intraperitoneal chemotherapy” |
| title_full_unstemmed | Response to Comment on “Heterogeneity in PD-L1 expression in malignant peritoneal mesothelioma with systemic or intraperitoneal chemotherapy” |
| title_short | Response to Comment on “Heterogeneity in PD-L1 expression in malignant peritoneal mesothelioma with systemic or intraperitoneal chemotherapy” |
| title_sort | response to comment on “heterogeneity in pd-l1 expression in malignant peritoneal mesothelioma with systemic or intraperitoneal chemotherapy” |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7961136/ https://www.ncbi.nlm.nih.gov/pubmed/33318658 http://dx.doi.org/10.1038/s41416-020-01215-7 |
| work_keys_str_mv | AT whitemichaelg responsetocommentonheterogeneityinpdl1expressioninmalignantperitonealmesotheliomawithsystemicorintraperitonealchemotherapy AT engolivers responsetocommentonheterogeneityinpdl1expressioninmalignantperitonealmesotheliomawithsystemicorintraperitonealchemotherapy |